KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Invested Capital (2016 - 2026)

Staar Surgical's Invested Capital history spans 17 years, with the latest figure at $344.2 million for Q1 2026.

  • For Q1 2026, Invested Capital fell 13.38% year-over-year to $344.2 million; the TTM value through Jan 2026 reached $344.2 million, down 13.38%, while the annual FY2026 figure was $344.2 million, 13.38% down from the prior year.
  • Invested Capital reached $344.2 million in Q1 2026 per STAA's latest filing, down from $353.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $428.1 million in Q3 2024 to a low of $276.3 million in Q2 2022.
  • Average Invested Capital over 5 years is $357.2 million, with a median of $351.9 million recorded in 2025.
  • Peak YoY movement for Invested Capital: increased 29.06% in 2022, then fell 17.73% in 2025.
  • A 5-year view of Invested Capital shows it stood at $336.1 million in 2022, then rose by 14.83% to $386.0 million in 2023, then rose by 2.95% to $397.3 million in 2024, then dropped by 10.96% to $353.8 million in 2025, then decreased by 2.71% to $344.2 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Invested Capital are $344.2 million (Q1 2026), $353.8 million (Q3 2025), and $336.6 million (Q2 2025).